Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Withdrawn 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Breast 1

Conditions

Motor Activity 1 Breast Neoplasms 1

Interventions

Trastuzumab 86 Cyclophosphamide 67 Capecitabine 67 Paclitaxel 63 Docetaxel 57 Fulvestrant 52 Letrozole 50 Carboplatin 42 pembrolizumab 40 Lapatinib 38 Doxorubicin 36 Anastrozole 32 Vinorelbine 31 Bevacizumab 31 exemestane 28 Tamoxifen 25 Gemcitabine 25 Albumin-Bound Paclitaxel 25 Radiotherapy 21 Taxes 18 atezolizumab 17 Everolimus 17 130-nm albumin-bound paclitaxel 17 pertuzumab 16 Epirubicin 16 palbociclib 15 eribulin 14 Magnetic Resonance Spectroscopy 14 Ado-Trastuzumab Emtansine 14 Goserelin 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × High-Intensity Interval Training × Breast × Clear all

NCT04950010 2024-09-05

HEAT

University of Nebraska

Phase NA Terminated

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡